期刊文献+

糖皮质激素治疗感染性休克的疗效 被引量:3

Effect of low-dose glucocorticoids in septic shock
原文传递
导出
摘要 目的探讨小剂量糖皮质激素对纠正感染性休克和改善患者预后的作用。方法对2000年1月至2006年10月收治于首都医科大学宣武医院ICU的46例感染性休克患者进行回顾性研究。2000年1月至2002年10月收治的24例患者未接受糖皮质激素治疗,为对照组(n=24);2002年11月至2006年10月收治的22例患者接受了糖皮质激素治疗,为治疗组(n=22)。除糖皮质激素应用外,两组患者在其他治疗方法上无明显差别。比较两组患者在纠正休克和转归方面的差异。结果治疗组(72.73)在治疗第7天时休克纠正比率明显高于对照组(41.67)(P〈0.05)。治疗组治疗48~72h后CRP明显低于对照组[(20.05±4.06)mg/dl vs.(23.55±4.93)mg/dl],而治疗3d后APACHEⅡ也低于对照组[(16.76±4.87)vs.(21.45±4.02)]。而两组患者在呼吸机治疗时间、住ICU时间、MODS发生率和死亡率方面差异无统计学意义(P〉0.05)。结论对顽固性感染性休克患者应用小剂量糖皮质激素可有效地纠正休克,更早地撤离血管活性药物,并明显降低炎症反应程度,但其对患者的远期预后影响值得进一步研究。 Objective To study retrospectively the effects of low-dose glucocorticoids in outcomeof septic shock. Method The present study was carried out by analysis of septic shock patients treated with norepinephrine or dopamine. A total of 46 patients with a confirmed diagnosis of septic shock admitted from January 2000 to October 2006 were divided into two groups: (1)glucocorticoids treatment group (n = 22), treated with glucocorticoids in addition to conventional treatment from November 2002 to October 2006; (2) control group ( n = 24), only treated with routine treatment from January 2000 to October 2002. The differences in outcome were compared between the two groups. Results The duration of of vasopressor support was significantly shorter in treatment group compared with control group. The percentage of shock reversal at 7 days was higher in treatment group than that in control group (72.73% vs. 41.67%, P = 0.034). Furthermore, a reduction in C-reactive protein(CRP) indicated inhibition of inflammatory response due to the effect of glucocorticoids in treatment group within 48-72 hours from admission to ICU(20.05 ± 4.06 mg/dl vs. 23.55± 4.93 mg/dl, P = 0.015). Therefore, APACHEⅡ score on 3^rd day was significantly lower in treatment group than that in control group( 16.76 ± 4.87 vs. 21.45 ± 4.02, P = 0. 001). However, there were no statistical significanees in the duration of mechanical ventilation, the length of ICU stay, the incidence of multiple organ dysfunction syndrome (MODS) and hospital-mortality between the two groups (P 〉 0.05). Conclusions Treatment with low-dose glucocorticoids could effectively accelerate the recovery from refractory septic shock and the early withdrawal of vasopressor. It seems to be associated with the reduced production of CRP, suggesting the effects of low-dose glucocorticoids on both stabilization of hemodynamics and inhibition of inflammatory response. The beneficial effects of low-dose steroids regimens on long-term outcome of patients with septic shock have not determined.
出处 《中华急诊医学杂志》 CAS CSCD 2008年第5期513-516,共4页 Chinese Journal of Emergency Medicine
关键词 休克 严重感染 糖皮质激素 血流动力学 脏器功能衰竭 Shock Sepsis Glucocorticoids Hemodynamics Organ failure
  • 相关文献

参考文献12

  • 1Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature [ J ]. Crit Care Med, 1995, 23(8) : 1430-1439.
  • 2Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J]. JAMA, 2002, 288(7):862-871.
  • 3Minneci PC, Deans KJ, Banks SM, et al. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose [ J ]. Ann Intern Med, 2004,141 ( 1 ) :47-56.
  • 4Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study [J]. Am J Respir Crit Care Med, 2005, 171(3):242-248.
  • 5Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients [J]. N Engl J Med, 2003, 348(8) :727-734.
  • 6Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis[ J]. BMJ, 2004, 329(7464):480.
  • 7Keh D, Spnmg CL. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review[J]. Crit Care Med, 2004, 32( 11 Suppl) :S527-S533.
  • 8Burry LD, Wax RS. Role of corticosteroids in septic shock [J]. Ann Pharmacother, 2004, 38(3) :464-472.
  • 9Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock [J]. Crit Care Med ,2004, 32(3) :858-873.
  • 10成人严重感染与感染性休克血流动力学监测与支持指南[J].中华急诊医学杂志,2007,16(2):121-126. 被引量:69

二级参考文献4

  • 1Dellinger P,Carlet JM,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].Intensive Care Med,2004,30 (6):536-555.
  • 2Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Eagl J Med,2001,345 (11):1368-1377.
  • 3Brunkhorst FM.Epidemiology,economy and practice--results of the German study on prevalence by the competence network sepsis (SepNet)[J].Anasthesiol Intensivmed Notfallmed Schmerzther,2006,41 (1):43-44.
  • 4Scott T,Roubinian N,Heuring T,et al.Before-after study of a standardized hospital order set for the management of septic shock[J].Crit Care Med,2006,34 (23):2707-2713.

共引文献88

同被引文献32

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部